Medical & Health
Rehabilitation systems Market Report 2026
Rehabilitation systems..
View product details
| 274 |
Feb-2026
$0.00 Ex Tax: $0.00
Rehabilitation Training Machines Market Report 2026
Rehabilitation Training Machines..
View product details
| 325 |
Feb-2026
$0.00 Ex Tax: $0.00
Rehabilitation wall bars Market Report 2026
Rehabilitation wall bars..
View product details
| 460 |
Feb-2026
$0.00 Ex Tax: $0.00
Rehmannia glutinosa Libosch Market Report 2026
Rehmannia glutinosa Libosch..
View product details
| 312 |
Feb-2026
$0.00 Ex Tax: $0.00
Rehmanniae radix Market Report 2026
Rehmanniae radix..
View product details
| 334 |
Feb-2026
$0.00 Ex Tax: $0.00
Relapsed Acute Myeloid Leukemia Drug Market Report 2026
Relapsed Acute Myeloid Leukemia Drug..
View product details
| 454 |
Feb-2026
$0.00 Ex Tax: $0.00
Relapsed Multiple Myeloma Drug Market Report 2026
Relapsed Multiple Myeloma Drug..
View product details
| 441 |
Feb-2026
$0.00 Ex Tax: $0.00
Relapsing Multiple Sclerosis (RMS) Drug Market Report 2026
Relapsing Multiple Sclerosis (RMS) Drug..
View product details
| 362 |
Feb-2026
$0.00 Ex Tax: $0.00
Relaxation beds Market Report 2026
Relaxation Beds..
View product details
| 359 |
Feb-2026
$0.00 Ex Tax: $0.00
Remanufactured Medical Imaging Device Market Report 2026
Remanufactured Medical Imaging Device..
View product details
| 316 |
Feb-2026
$0.00 Ex Tax: $0.00
Remicade (infliximab) Drug Market Report 2026
Remicade (infliximab) Drug..
View product details
| 339 |
Feb-2026
$0.00 Ex Tax: $0.00
Remicade Biosimilar Market Report 2026
Remicade Biosimilar..
View product details
| 291 |
Feb-2026
$0.00 Ex Tax: $0.00
Remifentanil HCl (CAS 132539-07-2) Market Report 2026
Remifentanil HCl..
View product details
| 291 |
Feb-2026
$0.00 Ex Tax: $0.00
Remifentanil Hydrochloride Market Report 2026
Remifentanil Hydrochloride..
View product details
| 299 |
Feb-2026
$0.00 Ex Tax: $0.00